Visualization of Knowledge Graphs and Retrospective Assessment of Genetic Studies in Pediatric Cardiomyopathy (2000–2024)
By
Xiaohua Han
Feng Wang
Guifang Wang
June 2, 2026
Clinical Scorecard: Visualization of Knowledge Graphs and Retrospective Assessment of Genetic Studies in Pediatric Cardiomyopathy (2000–2024)
At a Glance
Category Detail
Condition Pediatric Cardiomyopathy Key Mechanisms Genetic abnormalities leading to myocardial dysfunction Target Population Children with cardiomyopathy Care Setting Pediatric healthcare
Key Highlights
Pediatric cardiomyopathy is a leading cause of heart failure and sudden cardiac death in children. Research has evolved from single-gene screening to precision medicine with dynamic monitoring. The U.S., China, and the U.K. are core publishing nations in pediatric cardiomyopathy genetics. Guideline-Based Recommendations
Diagnosis
Improving early screening and genetic counseling is a key priority. Management
Targeted management strategies are essential for affected children. Monitoring & Follow-up
Dynamic monitoring supports personalized risk assessment. Risks
Approximately 1/3 of affected children may die or require heart transplantation. Patient & Prescribing Data
Children diagnosed with cardiomyopathy
Genetic testing technologies are crucial for diagnosis and risk assessment.
Clinical Best Practices
Utilize multi-omics technologies for precise classification. Incorporate artificial intelligence in genetic testing for improved outcomes. Related Resources & Content
